Internal Medicine, Rheumatology · Muncie, IN
NPI
1932220035
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
1107 S Tillotson Ave
Muncie, IN, 47304
Phone (765) 717-5399
Groups this clinician bills Medicare through
Medicare paid, 2024
$662K
90,939 services
Medicare patients, 2024
706
Average age 71
Drug cost, 2024
$6.3M
5,509 prescriptions
Company payments, 2025
$2,161
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tarek Kteleh was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 73,201 times for 73 patients. In total Tarek Kteleh billed 90,939 services in 42 codes, and Medicare paid $662K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-10.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 73,201 | 73 | $3.59 | $263K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 5,526 | 40 | $33.12 | $183K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 5,271 | 19 | $8.96 | $47K |
| 99214 Office E&M - Established | Office | 394 | 353 | $83.66 | $33K |
| 96401 Chemotherapy Administration | Office | 337 | 72 | $51.40 | $17K |
| 99204 Office E&M - New | Office | 284 | 284 | $99.30 | $28K |
| 86160 Immunoassay | Office | 129 | 65 | $11.51 | $1,485 |
| 96365 Intravenous Infusion, Hydration | Office | 119 | 74 | $44.62 | $5,309 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 102 | 22 | $0.66 | $67.31 |
| 85651 Clinical Chemistry | Office | 88 | 85 | $4.12 | $362 |
| 85025 Blood Count | Office | 86 | 83 | $7.49 | $644 |
| 86140 Clinical Chemistry | Office | 86 | 83 | $5.00 | $430 |
| 80076 Clinical Chemistry | Office | 82 | 79 | $7.88 | $646 |
| 80048 Clinical Chemistry | Office | 82 | 79 | $8.16 | $669 |
| 86430 Immunoassay | Office | 73 | 73 | $5.91 | $431 |
By year: 2022 $1.0M for 123,108 services; 2023 $730K for 84,548 services; 2024 $662K for 90,939 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 86160 Immunoassay | 129 | 65 | $11.51 | $1,485 |
| 85651 Clinical Chemistry | 88 | 85 | $4.12 | $362 |
| 85025 Blood Count | 86 | 83 | $7.49 | $644 |
| 86140 Clinical Chemistry | 86 | 83 | $5.00 | $430 |
| 80048 Clinical Chemistry | 82 | 79 | $8.16 | $669 |
| 80076 Clinical Chemistry | 82 | 79 | $7.88 | $646 |
| 86430 Immunoassay | 73 | 73 | $5.91 | $431 |
| 82550 Clinical Chemistry | 71 | 71 | $6.26 | $444 |
| 84443 Clinical Chemistry | 64 | 64 | $16.11 | $1,031 |
| 82607 Clinical Chemistry | 64 | 64 | $14.46 | $926 |
Medicare prescription drug claims, 2024
In 2024, the drug Tarek Kteleh prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,230 prescriptions and refills. In total Tarek Kteleh wrote 5,509 Medicare prescriptions that cost $6.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,230 | 2,188 | 449 | $31K |
| Methotrexate Methotrexate Sodium | 683 | 1,336 | 314 | $14K |
| Prednisone Generic | 478 | 774 | 197 | $2,744 |
| Methylprednisolone Generic | 277 | 277 | 175 | $1,524 |
| Leflunomide Generic | 235 | 503 | 105 | $15K |
| Gabapentin Generic | 212 | 339 | 85 | $3,128 |
| Enbrel Sureclick Etanercept | 183 | 183 | 32 | $1.4M |
| Tramadol Hcl Generic | 176 | 176 | 46 | $1,663 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 172 | 172 | 54 | $3,723 |
| Diclofenac Sodium Generic | 120 | 145 | 47 | $2,009 |
| Humira(Cf) Pen Adalimumab | 111 | 115 | 19 | $896K |
| Meloxicam Generic | 102 | 165 | 32 | $361 |
| Folic Acid Generic | 101 | 228 | 44 | $863 |
| Rinvoq Upadacitinib | 96 | 96 | 20 | $625K |
| Tizanidine Hcl Generic | 93 | 158 | 40 | $838 |
Brand drugs: - claims; generic drugs: 4,593 claims; opioid claims: 392.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tarek Kteleh $2,161 ($2,161 in general payments such as food, travel and fees) from 13 companies. The largest payer was Abbvie Inc. with $752.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 57 | $752 |
| Pfizer Inc. PFE | 26 | $283 |
| Amgen Inc. AMGN | 22 | $276 |
| Novartis Pharmaceuticals Corporation NVS | 29 | $276 |
| ANI Pharmaceuticals, Inc. ANIP | 8 | $136 |
| Janssen Biotech, Inc. JNJ | 4 | $121 |
| Mallinckrodt Hospital Products Inc. | 4 | $88.43 |
| UCB, Inc. UCB.BR | 3 | $71.46 |
| Organon LLC OGN | 2 | $45.94 |
| Lilly USA, LLC LLY | 2 | $36.07 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.